Engineered Luminescent Oncolytic Vaccinia Virus Activation of Photodynamic‐Immune Combination Therapy for Colorectal Cancer

Abstract

Oncolytic virus therapy is currently regarded as a promising approach in cancer immunotherapy. It has greater therapeutic advantages for colorectal cancer that is prone to distant metastasis. However, the therapeutic efficacy and clinical application of viral agents alone for colorectal cancer remain suboptimal. In this study, we developed an engineered oncolytic vaccinia virus (OVV‐Luc) that expresses the firefly luciferase gene and loaded Chlorin e6 (Ce6) onto the virus surface through covalent coupling, resulting in OVV‐Luc@Ce6 (OV@C). The OV@C infiltrates tumor tissue and induces endogenous luminescence through substrate catalysis, resulting in the production of reactive oxygen species. This unique system eliminates the need for an external light source, making it suitable for photodynamic therapy (PDT) in deep tissues. Moreover, this synergistic effect between PDT and viral immunotherapy enhances dendritic cell maturation, macrophage polarization, and reversal of the immunosuppressive microenvironment. This synergistic effect has the potential to convert a “cold” into “hot” tumor, it offers valuable insights for clinical translation and application.This article is protected by copyright. All rights reserved